JOHNSON & JOHNSON

Develops innovative medicines and medical technologies for complex diseases and personalized care.

JNJ | NYSE

Overview

Corporate Details

ISIN(s):: US4781601046
LEI:
Country:: United States of America
Address:: ONE JOHNSON & JOHNSON PLZ, 8933 NEW BRUNSWICK
Website:: https://www.jnj.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Johnson & Johnson is a global healthcare company engaged in the research, development, manufacturing, and sale of innovative medicines and medical technologies. The company operates through two core segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on developing science-based treatments for complex diseases in key therapeutic areas such as oncology, immunology, neuroscience, and cardiopulmonary. The MedTech segment innovates at the intersection of biology and technology, offering a portfolio of smarter, less invasive, and more personalized treatments in orthopaedics, surgery, cardiovascular health, and vision. By integrating its expertise across these two divisions, Johnson & Johnson addresses complex health challenges and aims to create a future where diseases are prevented, cured, and treatments are personalized.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all JOHNSON & JOHNSON filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JOHNSON & JOHNSON

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for JOHNSON & JOHNSON via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Armata Pharmaceuticals, Inc. Developing bacteriophage therapeutics for antibiotic-resistant infections.	United States of America	ARMP
AroCell AB Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.	Sweden	AROC
ArriVent BioPharma, Inc. A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.	United States of America	AVBP
ARROWHEAD PHARMACEUTICALS, INC. Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.	United States of America	ARWR
ARS Pharmaceuticals, Inc. Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.	United States of America	SPRY
ARTELO BIOSCIENCES, INC. Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.	United States of America	ARTL
Artiva Biotherapeutics, Inc. Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.	United States of America	ARTV
Ascelia Pharma Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.	Sweden	ACE
Ascendis Pharma A/S Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.	United States of America	ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.	United States of America	AAPG